Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.
RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ: GCTK), a medical technology company, announced the successful completion of its first in human clinical study for a novel continuous glucose monitoring ...
For athletes with diabetes, continuous glucose monitors are game-changers, helping them avoid dangerous blood sugar crashes ...
New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms ...